Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer

[1]  R. McLendon,et al.  Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination , 2017, Clinical Cancer Research.

[2]  E. Yeh,et al.  Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy , 2016, npj Breast Cancer.

[3]  T. Curry,et al.  Ovarian cancer: involvement of the matrix metalloproteinases. , 2015, Reproduction.

[4]  M. Coleman,et al.  Cancer survival: the CONCORD-2 study – Authors' reply , 2015, The Lancet.

[5]  S. Hankinson,et al.  Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers , 2015, Steroids.

[6]  C. Söderberg-Nauclér,et al.  Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. , 2015, World journal of experimental medicine.

[7]  Katherine K. Matthews,et al.  Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. , 2014, Cancer research.

[8]  R. Kurman.  Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Abdul-Aleem Mohammad,et al.  Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target? , 2013, International journal of cancer.

[10]  G. Stragliotto,et al.  Survival in patients with glioblastoma receiving valganciclovir. , 2013, The New England journal of medicine.

[11]  G. Stragliotto,et al.  Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  T. Olsson,et al.  Changes to anti-JCV antibody levels in a Swedish national MS cohort , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  J. Hartman,et al.  High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes , 2013, PloS one.

[14]  G. Senthilkumar,et al.  Viral and bacterial aetiologies of epithelial ovarian cancer , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[15]  Yan-ling Hu,et al.  Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and Cathepsin L in diagnosis of ovarian cancer , 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[16]  D. Zurakowski,et al.  Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. , 2011, Gynecologic oncology.

[17]  C. Cobbs.  Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis , 2011, Herpesviridae.

[18]  P. Siesjö,et al.  Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. , 2011, The Journal of clinical investigation.

[19]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[20]  C. Rancourt,et al.  Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells , 2011, British Journal of Cancer.

[21]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[22]  P. Eriksson,et al.  Infection with Human Cytomegalovirus Alters the MMP-9/TIMP-1 Balance in Human Macrophages , 2008, Journal of Virology.

[23]  D. Coen,et al.  Phosphorylation of Retinoblastoma Protein by Viral Protein with Cyclin-Dependent Kinase Function , 2008, Science.

[24]  Richard D. Smith,et al.  Human Cytomegalovirus UL97 Kinase Activity Is Required for the Hyperphosphorylation of Retinoblastoma Protein and Inhibits the Formation of Nuclear Aggresomes , 2008, Journal of Virology.

[25]  J. Sinclair.  Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  C. Cobbs,et al.  Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. , 2008, Cancer research.

[27]  O. Mandelboim,et al.  Tumor and viral recognition by natural killer cells receptors. , 2006, Seminars in cancer biology.

[28]  Rob Leurs,et al.  Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis , 2006, Proceedings of the National Academy of Sciences.

[29]  Ofer Levi,et al.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus , 2005, Nature Immunology.

[30]  Yoon-Jae Song,et al.  Inhibition of Cell Division by the Human Cytomegalovirus IE86 Protein: Role of the p53 Pathway or Cyclin-Dependent Kinase 1/Cyclin B1 , 2005, Journal of Virology.

[31]  D. Abate,et al.  Major Human Cytomegalovirus Structural Protein pp65 (ppUL83) Prevents Interferon Response Factor 3 Activation in the Interferon Response , 2004, Journal of Virology.

[32]  C. Söderberg-Nauclér,et al.  Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus‐negative blood donors , 2004, Transfusion.

[33]  Jindrich Cinatl,et al.  Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. , 2004, FEMS microbiology reviews.

[34]  T. Shenk,et al.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Cobbs,et al.  High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. , 2003, The Journal of urology.

[36]  B. Plachter,et al.  Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. , 2003, Blood.

[37]  Kirby I Bland,et al.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer , 2002, The Lancet.

[38]  Thomas Shenk,et al.  Altered Cellular mRNA Levels in Human Cytomegalovirus-Infected Fibroblasts: Viral Block to the Accumulation of Antiviral mRNAs , 2001, Journal of Virology.

[39]  M. Jackson,et al.  Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Kieff,et al.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Gingeras,et al.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Fortunato,et al.  Cell Cycle Dysregulation by Human Cytomegalovirus: Influence of the Cell Cycle Phase at the Time of Infection and Effects on Cyclin Transcription , 1998, Journal of Virology.

[43]  S. Larsson,et al.  Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time , 1998, Transfusion.

[44]  T. Shenk,et al.  Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Fish,et al.  Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors , 1997, Cell.

[46]  S. Huong,et al.  Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters , 1995, Journal of virology.

[47]  S. Larsson,et al.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection , 1993, Journal of virology.

[48]  R. Stenberg,et al.  Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products , 1989, Journal of virology.

[49]  L. Grillner.  Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests. , 1987, Journal of virological methods.

[50]  R. McLendon,et al.  Long-term Survival in Glioblastoma with Cytomegalovirus pp 65-Targeted Vaccination , 2017 .

[51]  M. Coleman,et al.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.

[52]  A. Russo,et al.  Hereditary ovarian cancer. , 2009, Critical reviews in oncology/hematology.